OptimizeRx OPRX. Buy. Platform Potential Continues to Grow $0.87 $4.00. Refer to the last two pages of this report for Disclosures

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "OptimizeRx OPRX. Buy. Platform Potential Continues to Grow $0.87 $4.00. Refer to the last two pages of this report for Disclosures"

Transcription

1 Nov 14, 2014 Healthcare OptimizeRx Platform Potential Continues to Grow Other OTC OPRX Buy Rating Unchanged Current Price $0.87 Target Price $4.00 Market Capitalization 20.32M Shares Outstanding 23.36M Float 11.13M Institutional Holdings 4.00% 12-month Low/High $0.85/$2.12 Average 90-day Volume 44,555 Fiscal Year End Dec 31 Despite an earnings shortfall in the quarter, the company continues to make progress expanding its drug company and network distribution relationships, thereby improving the growth potential of its core pharmaceutical platform Reported third quarter 2014 EPS of -$0.02, which was less than our forecast and the street consensus forecast of $0.00; slippage largely due to 5% revenue shortfall, gross margin shortfall and stock compensation expense overage Revenue growth was 18% year-over-year and 11% sequentially, both strong numbers but, negatively impacted by external issues with Allscripts (MDRX: Not Rated), a major distribution partner; all issues with Allscripts have been resolved Company expects to nearly double distribution network capacity from approximately 65,000 active users today by the middle of 2015 Reducing 2014 and 2015 EPS forecasts from -$0.03 and $0.08 to -$0.04 and $0.05, respectively, but maintaining 2016 EPS forecast of $0.20; price target remains $4 Equity Research Vincent Colicchio, CFA, Senior Research Analyst, Business Services & Software (561) Noble Financial Capital Markets Trading: (561) Sales: (561) Refer to the last two pages of this report for Disclosures Revenues ($ MIL) Period 2013A 2014E 2015E Q1 0.67A 1.32A 1.92E Q2 1.10A 1.45A 2.12E Q3 1.37A 1.62A 3.08E Q4 1.81A 1.94E 4.12E 4.96A 6.34E 11.25E EPS ($ MIL) Period Q1 2013A 2014E 2015E (0.01)A (0.04)A 0.00E Q2 0.01A 0.00A 0.01E Q3 0.00A (0.02)A 0.01E Q4 0.01E 0.02E 0.01A (0.04)E NA 0.05E Page: 1 of 10

2 Investment Thesis We expect the company to grow rapidly over several years as the pharmaceutical industry shifts marketing dollars from sales representatives toward the company's core pharmaceutical platform. Continued growth of distribution capacity and pharmaceutical clients, as well as brand expansion at existing clients, should be the key growth drivers. Favorable trends, which include rapid growth of e-prescribing activity and physician time pressures, should continue to provide tailwinds for the company's pharmaceutical platform business. Other products, such as the company's veterinarian pharmaceutical platform, should provide a meaningful contribution over time. Despite an earnings shortfall in the quarter, the company continues to make progress expanding its drug company and network distribution relationships, thereby improving the growth potential of its core pharmaceutical platform. Importantly, external issues with Allscripts (MDRX: Not Rated) that adversely impacted distributions in the first three quarters of 2014 have been resolved. Third Quarter 2014 Earnings Review The company reported third quarter 2014 EPS of -$0.02, which was less than our forecast and the street consensus forecast of $0.00. The EPS slippage versus our forecast was primarily due to a revenue shortfall of 5%, an 800 basis point shortfall in gross margins and a 78% overage in stock compensation expenses. The following analysis compares third quarter 2014 results with (restated) third quarter 2013 results rather than third quarter 2013 results, as initially reported, to make the comparison more meaningful. The initial third quarter 2013 results were restated due to a change in the way the company accounts for revenue share expense. Total revenue increased 18% year-over-year from $1.4 million in third quarter 2013 and 11% sequentially from $1.5 million in second quarter 2014 to $1.6 million in third quarter The main source of revenue for the company remains SampleMD, which grew in the quarter due to an increase in the number of pharmaceutical brands marketed by the platform and expansion of the number of distribution channels. Importantly, all revenue categories, which include set up fees, reporting fees and distributions grew year-over-year and sequentially. The company's gross margin declined year-over-year from 61.5% in third quarter 2013 and sequentially from 62.9% in second quarter 2014 to 47% in third quarter The decline in gross margins was caused by a faster increase in revenue share expense than revenue, which means that distribution revenue grew as a portion of the mix. Non distribution revenue, such as set up fees and reporting fees, tend to generate higher margins than distribution revenue. In addition, the company started paying 10% of net revenue on all distribution revenue to LDM this year, which had a negative impact on the comparison with last year. In a legal settlement with LDM, the company agreed to pay a distribution fee on all SampleMD revenue in exchange for nonexclusive use of LDM's intellectual property. Adjusted EBITDA margins, which excludes depreciation and amortization, and stock compensation expenses, Page: 2 of 10

3 declined year-over-year from 13% in third quarter 2013 and sequentially from 16% in second quarter 2014 to 8% in third quarter The sequential decline was caused by lower gross margins and a large increase in stock compensation costs. Balance Sheet & Cash Flow Update As of the close of third quarter 2014, the company had a strong balance sheet, consisting of $3.3 million of cash and cash equivalents, no long-term debt and $4.9 million of shareholders' equity. During the quarter, the company generated a cash from operations loss of $622.3 thousand and a free cash flow loss of $761.2 thousand. We define free cash flow as cash from operations less capital spending and capitalized software development expenses. Core Platform Outlook Appears Robust The outlook for the company's core platform remains compelling given continued growth in the number of pharmaceutical brands available for promotion and continued expansion of distribution channels. The company continued to acquire new pharmaceutical partners and brands from existing partners in the quarter. Most recently, in August, the company launched its SampleMD solution within Quest Diagnostic's Care360 electronic health record (EHR) system. Impressively, management expects the number of active users to increase from approximately 65,000 today to nearly twice that number by the middle of A key driver will be the expected addition next year of two large health systems, which are users of the EPIC EHR system. This will be an important event since EPIC, a major EHR player, has been hesitant to partner with the company. The change is being driven by the users, which have urged EPIC to add the system. The addition of these two health systems could set a precedent that encourages other EPIC users to demand access. Another growth driver may emerge next year through the company's veterinarian pharmaceutical platform, which is scheduled for a beta test in the first quarter of This product may contribute meaningful revenue in the second half of Page: 3 of 10

4 Earnings Model Update We are reducing our 2014 and 2015 EPS forecasts modestly from -$0.03 and $0.08 to -$0.04 and $0.05, respectively. In 2014, the EPS reduction was caused by a 4% reduction in our revenue forecast, to account for incremental weakness at Allscripts, and a 410 basis point reduction in our gross margin forecast. In 2015, the reduction in our EPS forecast was largely due to a 650 basis point reduction in our gross margin forecast. Our prior gross margin forecasts were not properly reflecting the dilutive impact of the LDM settlement. Importantly, we are maintaining our 2016 EPS forecast of $0.20. The key assumptions in our earnings model for 2014, 2015 and 2016 are as follows: 2014 model Revenue growth: 28%, gross margin: 54%, adjusted EBITDA margin: 8%, EPS growth: -397% 2015 model Revenue growth: 78%, gross margin: 49%, adjusted EBITDA margin: 22%, EPS growth: -208% 2016 model Revenue growth: 74%, gross margin: 51%, adjusted EBITDA margin: 33%, EPS growth: 315% Page: 4 of 10

5 Valuation Summary Our month price target for OPRX stock is $4, which is based on 20x our 2016 EPS forecast of $0.20. Our PEG-based valuation was derived by multiplying a 0.5x PEG by our estimate of a 40% five-year EPS compound annual growth rate (CAGR) and then multiplying the product, which is 20x, by our 2016 EPS forecast of $0.20. The 0.5x PEG multiple used in our valuation represents a steep discount to the peer group average multiple of 1.3x to (conservatively) account for liquidity risk. Our five-year EPS CAGR forecast of 40% assumes EPS growth of 315% in 2016 and 7% per year for 2017 through These growth rates are extremely conservative to account for the risks inherent in disruptive technology. The key risks for OPRX shares include the following: 1) large pharmaceutical companies and EHR vendors have substantial financial resources, which can be used to create competing products, 2) institutional resistance to change could slow the adoption of the company's service by pharmaceutical companies and physicians and 3) high revenue concentration with the company's top five clients, which comprised 63% of revenue in first nine months of Page: 5 of 10

6 Page: 6 of 10

7 Page: 7 of 10

8 Page: 8 of 10

9 DISCLAIMER All statements or opinions contained herein that include the words "we", "us", or "our" are solely the responsibility of Noble Financial and do not necessarily reflect statements or opinions expressed by any person or party affiliated with the company mentioned in this report. Any opinions expressed herein are subject to change without notice. All information provided herein is based on public and non-public information believed to be accurate and reliable, but is not necessarily complete and cannot be guaranteed. No judgment is hereby expressed or should be implied as to the suitability of any security described herein for any specific investor or any specific investment portfolio. The decision to undertake any investment regarding the security mentioned herein should be made by each reader of this publication based on its own appraisal of the implications and risks of such decision. This publication is intended for information purposes only and shall not constitute an offer to buy/sell or the solicitation of an offer to buy/sell any security mentioned in this report, nor shall there be any sale of the security herein in any state or domicile in which said offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or domicile. This publication and all information, comments, statements or opinions contained or expressed herein are applicable only as of the date of this publication and subject to change without prior notice. Past performance is not indicative of future results. IMPORTANT DISCLOSURES Within the past 30 days, a Noble Financial Company Research employee and/or their immediate supervisors have not effected a transaction for their own account(s) in the investment(s) referred to in this report, nor will such a transaction take place within 5 days of its publication. A Noble Financial Company has received compensation for investment banking services from the subject company in the past 12 months. A Noble Financial Company is not a market maker in the subject company. Page: 9 of 10

10 WARNING This report is intended to provide general securities advice, and does not purport to make any recommendation that any securities transaction is appropriate for any recipient particular investment objectives, financial situation or particular needs. Prior to making any investment decision, recipients should assess, or seek advice from their advisors, on whether any relevant part of this report is appropriate to their individual circumstances. If a recipient was referred to a Noble Financial Company by an investment advisor, that advisor may receive a benefit in respect of transactions effected on the recipients behalf, details of which will be available on request in regard to a transaction that involves a personalized securities recommendation. Additional risks associated with the security mentioned in this report that might impede achievement of the target can be found in its initial report issued by a Noble Financial Company. This report may not be reproduced, distributed or published for any purpose unless authorized by a Noble Financial Company. U.S. CLIENTS For purposes of distribution in the United States, this report is prepared for persons who can be defined as "Institutional Investors" under U.S. regulations. Any U.S. person receiving this report and wishing to effect a transaction in any security discussed herein, must do so through a U.S. registered broker or dealer. Noble International Investments, Inc. is a U.S. registered broker dealer. RESEARCH ANALYST CERTIFICATION Independence Of View All views expressed in this report accurately reflect my personal views about the subject securities or issuers. Receipt of Compensation All or part of my compensation was, is, or will be directly or indirectly related to the specific recommendations or views in the research report. Ownership and Material Conflicts of Interest Neither I nor anybody in my household has a financial interest in the securities of the subject company or any other company mentioned in this report. Additional information is available upon request. Any recipient of this report that wishes further information regarding the subject company or the disclosure information mentioned herein, should contact Noble Financial by mail or phone. Noble International Investments, Inc., dba Noble Financial Capital Markets is a FINRA registered broker/dealer. Member - SPIC (Securities Investor Protection Corporation) % OF STOCKS COVERED % OF IB CLIENTS BUY: potential return is >15% above the current price NFCM RATING DEFINITIONS 68% 35% HOLD: potential return is -15% to 15% of the current price 26% 2% SELL: potential return is >15% below the current price 0% 0% Report ID: 7861 Page: 10 of 10

OPTIMIZERx OPRX. Buy. Optimizing/Monetizing Pharmaceutical Distribution $0.90 $4.00. Refer to the last two pages of this report for Disclosures

OPTIMIZERx OPRX. Buy. Optimizing/Monetizing Pharmaceutical Distribution $0.90 $4.00. Refer to the last two pages of this report for Disclosures Oct 27, 2014 OPTIMIZERx Healthcare Optimizing/Monetizing Pharmaceutical Distribution Other OTC OPRX Expect company to grow rapidly for several years as pharmaceutical industry shifts marketing dollars

More information

Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3

Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3 Siddharth Rajeev, B.Tech, MBA, CFA Analyst November 5, 2015 Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3 Sector/Industry: E-commerce Market Data (as of November 5, 2015) Current Price $1.15 Fair

More information

Syncordia Technologies and Healthcare Solutions, Corp. Reports Second Quarter Fiscal 2016 Results

Syncordia Technologies and Healthcare Solutions, Corp. Reports Second Quarter Fiscal 2016 Results Syncordia Technologies and Healthcare Solutions, Corp. Reports Second Quarter Fiscal 2016 Results - Sequential growth of Revenue and Adjusted EBITDA of 15% and 10%, respectively Toronto, Ontario. November

More information

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value UK Daily Letter 1 K3 Business Technology Group KBT : AIM : 144p BUY Target: 215p Bob Liao, CFA 44.20.7050.6654 bliao@canaccordgenuity.com COMPANY STATISTICS: 52-week Range: 0.82-1.50 Avg. Daily Vol. (000s):

More information

Performance Food Group Company Reports First-Quarter Fiscal 2016 Earnings

Performance Food Group Company Reports First-Quarter Fiscal 2016 Earnings NEWS RELEASE For Immediate Release November 4, 2015 Investors: Michael D. Neese VP, Investor Relations (804) 287-8126 michael.neese@pfgc.com Media: Joe Vagi Manager, Corporate Communications (804) 484-7737

More information

HORIZON GLOBAL DELIVERS PROFIT IMPROVEMENT FOR THIRD CONSECUTIVE QUARTER

HORIZON GLOBAL DELIVERS PROFIT IMPROVEMENT FOR THIRD CONSECUTIVE QUARTER FOR IMMEDIATE RELEASE CONTACT: Maria C. Duey Vice President, Corporate Development & Investor Relations (248) 593-8810 mduey@horizonglobal.com HORIZON GLOBAL DELIVERS PROFIT IMPROVEMENT FOR THIRD CONSECUTIVE

More information

Management s Discussion and Analysis

Management s Discussion and Analysis Management s Discussion and Analysis of Financial Conditions and Results of Operations For the quarter and six months ended June 30, 2012 All figures in US dollars This Interim Management s Discussion

More information

Automatic Data Processing, Inc. and Subsidiaries Consolidated Statements of Earnings (In millions, except per share amounts) (Unaudited)

Automatic Data Processing, Inc. and Subsidiaries Consolidated Statements of Earnings (In millions, except per share amounts) (Unaudited) Automatic Data Processing, Inc. and Subsidiaries Consolidated Statements of Earnings (In millions, except per share amounts) (Unaudited) 2006 (B) 2005 (C) 2006 (B) 2005 (C) Revenues, other than interest

More information

For Immediate Release Toronto Stock Exchange Symbol: RC

For Immediate Release Toronto Stock Exchange Symbol: RC For Immediate Release Toronto Stock Exchange Symbol: RC RDM Corporation Reports Third Quarter Financial Results Payment Processing Services Revenue grows 15% year over year WATERLOO, ON, July 26, 2012

More information

Numerex Reports First Quarter 2015 Financial Results

Numerex Reports First Quarter 2015 Financial Results May 11, 2015 Numerex Reports First Quarter 2015 Financial Results ATLANTA, May 11, 2015 (GLOBE NEWSWIRE) -- Numerex Corp (Nasdaq:NMRX), a leading provider of on-demand and interactive machine-to-machine

More information

China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010

China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 Annual Revenue up 34.4% to RMB 261.5 Million Fiscal 2010 New Subscribers grew 30.5% Conference Call

More information

Canadian Tire Corporation 2014 Second Quarter Financial Results

Canadian Tire Corporation 2014 Second Quarter Financial Results Canadian Tire Corporation 2014 Second Quarter Financial Results August 7, 2014 Forward looking information This document contains forward-looking statements that reflect management s current expectations

More information

Formal script: Call to order, introductions, matters for vote.

Formal script: Call to order, introductions, matters for vote. 1 Formal script: Call to order, introductions, matters for vote. 2 Before I get started, you should know that the presentation you are about to hear contains forward looking statements. As you should read

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Q3 results subdued, Outlook remains good; BUY January 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs4,103 Target Price Rs4,844 Implied Upside 18.1% Sensex 24,470 Nifty

More information

WuXi PharmaTech Announces Second-Quarter 2014 Results

WuXi PharmaTech Announces Second-Quarter 2014 Results WuXi PharmaTech Announces Second-Quarter 2014 Results SHANGHAI, August 13, 2014 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving

More information

OptimizeRx Corporation (OPRX) Pharma/EHR Conference Revelations Strengthen Our Long-Term Outlook; Reiterate BUY, $3.00 Target

OptimizeRx Corporation (OPRX) Pharma/EHR Conference Revelations Strengthen Our Long-Term Outlook; Reiterate BUY, $3.00 Target MERRIMAN CAPITAL Pharma/EHR Conference Revelations Strengthen Our Long-Term Outlook; Reiterate BUY, $3.00 Target Brian Murphy (646) 292-1411 bmurphy@merrimanco.com October 3, 2014 Key Metrics Price: $1.20

More information

NATIONSTAR REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS & STRATEGIC ACQUISITION

NATIONSTAR REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS & STRATEGIC ACQUISITION Contact: Marshall Murphy (469) 549-3005 FOR IMMEDIATE RELEASE NATIONSTAR REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS & STRATEGIC ACQUISITION GAAP EPS of $0.27 Pro forma EPS of $0.53, including impact

More information

Fidelity Bankshares, Inc.

Fidelity Bankshares, Inc. Savings & Loans October 19, 2005 Gary P. Tenner, CFA 404 926-5156 Ö~êó íéååéê]êüåçkåçã= Lauren M. Johnson 404-926-5438 ä~ìêéå àçüåëçå]êüåçkåçã= ==== Summary Fidelity Bankshares, Inc. Rating: Neutral Estimate

More information

ADP REPORTS FOURTH QUARTER AND FISCAL 2011 RESULTS; PROVIDES FISCAL 2012 GUIDANCE

ADP REPORTS FOURTH QUARTER AND FISCAL 2011 RESULTS; PROVIDES FISCAL 2012 GUIDANCE FOR IMMEDIATE RELEASE ADP REPORTS FOURTH QUARTER AND FISCAL 2011 RESULTS; PROVIDES FISCAL 2012 GUIDANCE For the Year, Revenues Rise 11%, 6% Organic; EPS from Continuing Operations up 6% (excluding certain

More information

OMEGA HEALTHCARE INVESTORS, INC. FUNDS FROM OPERATIONS Unaudited (In thousands, except per share amounts) Pro Forma Analysis

OMEGA HEALTHCARE INVESTORS, INC. FUNDS FROM OPERATIONS Unaudited (In thousands, except per share amounts) Pro Forma Analysis OMEGA HEALTHCARE INVESTORS, INC. FUNDS FROM OPERATIONS (In thousands, except per share amounts) Net income available to common stockholders. $ 25,592 Deduct gain from real estate dispositions.. (11,806)

More information

617-444-3913 617-274-7130 AKAMAI REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS

617-444-3913 617-274-7130 AKAMAI REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS FOR IMMEDIATE RELEASE Contacts: Jeff Young Tom Barth Media Relations Investor Relations Akamai Technologies Akamai Technologies 617-444-3913 617-274-7130 jyoung@akamai.com tbarth@akamai.com AKAMAI REPORTS

More information

March 31, 2014 Income from operations... $ 121,521 $ 136,082 $ 120,847

March 31, 2014 Income from operations... $ 121,521 $ 136,082 $ 120,847 Akamai Technologies, Inc. Reconciliation of GAAP to Non-GAAP Financial Measures In addition to providing financial measurements based on generally accepted accounting principles in the United States of

More information

No Signs of Cannibalization

No Signs of Cannibalization Tony Wible, CFA 908-470-3160 twible@janney.com Media and Entertainment Price: $84.98 Fair Value Estimate: $100.00 52-Week Range: $60.80 - $88.25 Market Cap (MM): $70,075 Shr.O/S-Diluted (mm): 824.6 Average

More information

3 rd Quarter 2014 Earnings Conference Call Transcript

3 rd Quarter 2014 Earnings Conference Call Transcript 3 rd Quarter 2014 Earnings Conference Call Transcript Overview*: BDC reported 3Q14 consolidated revenues of $613.1M, income from continuing operations of $50.4M and diluted EPS from continuing operations

More information

Waste Management Announces Second Quarter Earnings

Waste Management Announces Second Quarter Earnings FOR IMMEDIATE RELEASE Waste Management Announces Second Quarter Earnings Collection and Disposal Income from Operations Grows 3.4% HOUSTON July 26, 2012 Waste Management, Inc. (NYSE: WM) today announced

More information

Fixed Income Investments. Private Banking USA

Fixed Income Investments. Private Banking USA Fixed Income Investments Credit Suisse Securities (USA) llc Private Banking USA 2 Preservation of your wealth is our first priority. Introduction Fixed Income Investing Today In the last two decades, investors

More information

Large Cap Stock Funds

Large Cap Stock Funds Wells Fargo Advantage Funds December 1, 2014 Large Cap Stock Funds Prospectus Class R4* Capital Growth Fund WCGRX Intrinsic Value Fund EIVRX Large Cap Growth Fund SLGRX Premier Large Company Growth Fund

More information

Atrium Mortgage Investment Corporation (TSX: AI) Record Year / Shares at Attractive Entry Levels. Sector/Industry: Mortgage Investment Corporation

Atrium Mortgage Investment Corporation (TSX: AI) Record Year / Shares at Attractive Entry Levels. Sector/Industry: Mortgage Investment Corporation Siddharth Rajeev, B.Tech, MBA, CFA Analyst February 17, 2016 Atrium Mortgage Investment Corporation (TSX: AI) Record Year / Shares at Attractive Entry Levels Sector/Industry: Mortgage Investment Corporation

More information

COMPANY CONTACTS: Jay S. Hennick Founder & CEO. D. Scott Patterson President & COO (416) 960-9500

COMPANY CONTACTS: Jay S. Hennick Founder & CEO. D. Scott Patterson President & COO (416) 960-9500 COMPANY CONTACTS: Jay S. Hennick Founder & CEO D. Scott Patterson President & COO John B. Friedrichsen Senior Vice President & CFO (416) 960-9500 FOR IMMEDIATE RELEASE FirstService Reports Record Fourth

More information

NEWS RELEASE MFLEX ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS

NEWS RELEASE MFLEX ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS NEWS RELEASE Contact: Stacy Feit Investor Relations Tel: 213-486-6549 Email: investor_relations@mflex.com MFLEX ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS Fifth consecutive quarter of strong profitability

More information

OptimizeRx Corporation (OPRX)

OptimizeRx Corporation (OPRX) MERRIMAN CAPITAL The Fragmented EHR Landscape Is Ripe For Intermediation, OPRX Is Positioned Well; Reiterate BUY Brian Murphy (646) 292-1411 bmurphy@merrimanco.com March 27, 2015 Key Metrics Price: $1.37

More information

DST SYSTEMS, INC. ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS

DST SYSTEMS, INC. ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS KANSAS CITY, MO - October 22, 2015 DST Systems, Inc. (NYSE: DST) reported consolidated net income of $75.1 million ($2.08 per diluted share) for the third

More information

DOLLARAMA REPORTS STRONG SALES AND NET EARNINGS INCREASES TO CLOSE FISCAL YEAR 2011

DOLLARAMA REPORTS STRONG SALES AND NET EARNINGS INCREASES TO CLOSE FISCAL YEAR 2011 For immediate distribution DOLLARAMA REPORTS STRONG SALES AND NET EARNINGS INCREASES TO CLOSE FISCAL YEAR 2011 MONTREAL, Quebec, April 7, 2011 Dollarama Inc. (TSX: DOL) ( Dollarama or the Corporation )

More information

VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES THIRD QUARTER FINANCIAL RESULTS

VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES THIRD QUARTER FINANCIAL RESULTS FOR IMMEDIATE RELEASE VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES THIRD QUARTER FINANCIAL RESULTS Charlottesville, VA November 4, 2015 Virginia National Bankshares Corporation (OTCQX: VABK) (the

More information

Lending Club Reports Third Quarter 2015 Results Q3 operating revenue up 104% year-over-year to $115.1 million

Lending Club Reports Third Quarter 2015 Results Q3 operating revenue up 104% year-over-year to $115.1 million Lending Club Reports Third Quarter Results Q3 operating revenue up 104% year-over-year to $115.1 million SAN FRANCISCO October 29, Lending Club (NYSE:LC), the world s largest online marketplace connecting

More information

Sapiens results in the first quarter represent a solid start to achieving our financial targets for the full year.

Sapiens results in the first quarter represent a solid start to achieving our financial targets for the full year. Sapiens Reports 12% Year-Over-Year Increase in Quarterly Revenue to $41 Million Non-GAAP Quarterly Operating Profit Increased by 58.5% Year-Over-Year Holon, Israel, May 6, 2015 Sapiens International Corporation,

More information

Colleen Johnston Group Head Finance & CFO TD Bank Financial Group. Citi Financial Services Conference

Colleen Johnston Group Head Finance & CFO TD Bank Financial Group. Citi Financial Services Conference Colleen Johnston Group Head Finance & CFO TD Bank Financial Group Citi Financial Services Conference January 28, 2009 Caution regarding forward-looking statements From time to time, the Bank makes written

More information

CONVERTIBLE DEBENTURES A PRIMER

CONVERTIBLE DEBENTURES A PRIMER What are convertible debentures? CONVERTIBLE DEBENTURES A PRIMER They are hybrid securities, combining the features of a conventional debenture with the option of converting, under certain circumstances,

More information

DATRON AG. Investor day supports our positive view. Buy (Buy) 12.50 EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

DATRON AG. Investor day supports our positive view. Buy (Buy) 12.50 EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015 BANKHAUS LAMPE // 1 DATRON AG Investor day supports our positive view 17/09/2015 Buy (Buy) 12.50 EUR (12.50 EUR ) Close 15/09/2015 9.75 EUR Bloomberg: DAR GY WKN: A0V9LA Sector Engineering Share price

More information

NEXSTAR BROADCASTING THIRD QUARTER NET REVENUE INCREASES 21.1% TO RECORD $73.1 MILLION

NEXSTAR BROADCASTING THIRD QUARTER NET REVENUE INCREASES 21.1% TO RECORD $73.1 MILLION NEWS ANNOUNCEMENT FOR IMMEDIATE RELEASE NEXSTAR BROADCASTING THIRD QUARTER NET REVENUE INCREASES 21.1% TO RECORD $73.1 MILLION - Third Quarter Operating Income Rises to $12.9 Million; BCF Increases 54.5%;

More information

CENTRAL SECURITIES CLEARING SYSTEM PLC. CSCS: from West Africa to the rest of the world. Recommendation: BUY

CENTRAL SECURITIES CLEARING SYSTEM PLC. CSCS: from West Africa to the rest of the world. Recommendation: BUY CENTRAL SECURITIES CLEARING SYSTEM PLC NASD EQUITY NIGERIA FINANCIAL SERVICES CSCS: from West Africa to the rest of the world INVESTMENT HIGHLIGHT HALF YEAR 2015: Growing Revenue and Bottom-Line Amidst

More information

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

ITRON, INC. CONSOLIDATED STATEMENTS OF OPERATIONS , INC. CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except per share data) Revenues $ 497,590 $ 446,746 Cost of revenues 334,387 308,324 Gross profit 163,203 138,422 Operating expenses

More information

Keyware Technologies N.V- valuation highlights

Keyware Technologies N.V- valuation highlights Keyware Technologies N.V- valuation highlights This memorandum brings a short summary of Keyware Technologies N.V's (hereinafter 'Keyware' or the 'Company') valuation report as of December 31, 2014. This

More information

AT&T Investor Update. 2Q12 Earnings Conference Call July 24, 2012

AT&T Investor Update. 2Q12 Earnings Conference Call July 24, 2012 AT&T Investor Update Earnings Conference Call July 24, 2012 2012 AT&T Intellectual Property. All rights reserved. AT&T, the AT&T logo and all other marks contained herein are trademarks of AT&T Intellectual

More information

Year-end Dec 2013A 2014E 2015E 2016E Key data. # Priced at market close, 29/09/14

Year-end Dec 2013A 2014E 2015E 2016E Key data. # Priced at market close, 29/09/14 This research is intended for UK institutional investors only and market professionals. It is not intended for retail customers and any retail customer should seek professional, independent advice before

More information

AMN HEALTHCARE SERVICES INC

AMN HEALTHCARE SERVICES INC AMN HEALTHCARE SERVICES INC FORM 8-K (Current report filing) Filed 02/19/15 for the Period Ending 02/19/15 Address 12400 HIGH BLUFF DRIVE SUITE 100 SAN DIEGO, CA 92130 Telephone 8668718519 CIK 0001142750

More information

i-cthru Inc. Form ADV Part 2A Client Brochure

i-cthru Inc. Form ADV Part 2A Client Brochure i-cthru Inc. Tamarind Hill Road 33 Upper Prince s Quarter Saint Maarten, Dutch Caribbean Mailing address 1562 First Ave # 205-2863 New York, NY 10028-4004 USA http://www.i-cthru.com Form ADV Part 2A Client

More information

Understanding Financial Information for Bankruptcy Lawyers Understanding Financial Statements

Understanding Financial Information for Bankruptcy Lawyers Understanding Financial Statements Understanding Financial Information for Bankruptcy Lawyers Understanding Financial Statements In the United States, businesses generally present financial information in the form of financial statements

More information

Ituran Location & Control Ltd. In-line Quarter, Big Dividend, Maintain Outperform

Ituran Location & Control Ltd. In-line Quarter, Big Dividend, Maintain Outperform EQUITY RESEARCH COMPANY UPDATE February 23, 2012 Stock Rating: OUTPERFORM 12-18 mo. Price Target $16.00 ITRN - NASDAQ $13.47 3-5 Yr. EPS Gr. Rate 8% 52-Wk Range $16.96-$11.27 Shares Outstanding 21.0M Float

More information

3rd Quarter Fiscal 2016 Results Conference Call May 25, 2016

3rd Quarter Fiscal 2016 Results Conference Call May 25, 2016 3rd Quarter Fiscal 2016 Results Conference Call May 25, 2016 Looking Statements and Non-GAAP Information This presentation contains forward-looking statements. Other than statements of historical facts,

More information

ADP Reports Third Quarter Fiscal 2014 Results

ADP Reports Third Quarter Fiscal 2014 Results April 30, 2014 ADP Reports Third Quarter Fiscal 2014 Results Revenues Rise 7%, Nearly all Organic, to $3.3 Billion for the Quarter; EPS Rises 7% ROSELAND, N.J., April 30, 2014 (GLOBE NEWSWIRE) -- ADP (Nasdaq:ADP),

More information

news CTS CORPORATION Elkhart, Indiana 46514 574-523-3800

news CTS CORPORATION Elkhart, Indiana 46514 574-523-3800 - news CTS CORPORATION Elkhart, Indiana 46514 574-523-3800 FOR RELEASE: Immediately October 26, 2015 CTS ANNOUNCES THIRD QUARTER 2015 RESULTS Delivers solid operating results despite soft sales Addressing

More information

HP Inc. Reports Hewlett-Packard Company Fiscal 2015 Full-Year and Fourth Quarter Results

HP Inc. Reports Hewlett-Packard Company Fiscal 2015 Full-Year and Fourth Quarter Results HP Inc. 1501 Page Mill Road Palo Alto, CA 94304 hp.com News Release HP Inc. Reports Hewlett-Packard Company Fiscal 2015 Full-Year and Fourth Quarter Results Editorial contacts HP Inc. Media Relations MediaRelations@hp.com

More information

Small-Cap Research. CytoSorbents Cp (CTSO- NASDAQ) CTSO: Strong Recovery in Product Sales Following Sales Force Restructuring OUTLOOK SUMMARY DATA

Small-Cap Research. CytoSorbents Cp (CTSO- NASDAQ) CTSO: Strong Recovery in Product Sales Following Sales Force Restructuring OUTLOOK SUMMARY DATA Small-Cap Research January 14, 2016 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 111 North Canal Street, Chicago, IL 60606 CytoSorbents Cp (CTSO- NASDAQ) CTSO: Strong Recovery in

More information

Zebra Technologies Announces Record Sales for Second Quarter of 2006

Zebra Technologies Announces Record Sales for Second Quarter of 2006 FOR IMMEDIATE RELEASE Zebra Technologies Announces Record Sales for Second Quarter of 2006 Vernon Hills, IL, July 26, 2006 Zebra Technologies Corporation (NASDAQ: ZBRA) today announced that net income

More information

2013 Third Quarter Review October 25, 2013 1

2013 Third Quarter Review October 25, 2013 1 October 25, 213 1 Panalpina Group October 25, 213 213 Third Quarter Review October 25, 213 2 Highlights and key figures Operating and financial review Outlook Growth in profitability and margins in the

More information

Q3 2014 SHAREHOLDERS REPORT. A leading provider of independent commercial real estate consulting and advisory services, software and data solutions.

Q3 2014 SHAREHOLDERS REPORT. A leading provider of independent commercial real estate consulting and advisory services, software and data solutions. A leading provider of independent commercial real estate consulting and advisory services, software and data solutions. Q3 2014 SHAREHOLDERS REPORT THIRD QUARTER REPORT 2014 FOR THE NINE MONTHS ENDED SEPTEMBER

More information

Accenture Reports Third-Quarter Fiscal 2015 Results. -- Revenues of $7.8 billion, up 0.4% in U.S. dollars and 10% in local currency --

Accenture Reports Third-Quarter Fiscal 2015 Results. -- Revenues of $7.8 billion, up 0.4% in U.S. dollars and 10% in local currency -- Accenture Reports Third-Quarter Fiscal 2015 Results -- Revenues of $7.8 billion, up 0.4% in U.S. dollars and 10% in local currency -- -- EPS of $1.24 include a $0.06 non-cash pension settlement charge.

More information

Bright Smart (1428 HK)

Bright Smart (1428 HK) Equity Research Financials Bright Smart (1428 ) Hold (initiation) Target price: $1.70 Local broker with high ROE; initiate at Hold Local broker with expansion ambition Bright Smart is a securities, commodities

More information

Management Commentary. Second Quarter 2015 Results

Management Commentary. Second Quarter 2015 Results Management Commentary Second Quarter 2015 Results The RetailMeNot, Inc. ( RetailMeNot ) earnings call will begin on August 5, 2015 at 7:00am central time (8:00am eastern time) and will include prepared

More information

N E W S R E L E A S E

N E W S R E L E A S E N E W S R E L E A S E Investors: Brett Manderfeld John S. Penshorn Media: Don Nathan Tyler Mason Vice President Senior Vice President Senior Vice President Vice President 952-936-7216 952-936-7214 952-936-1885

More information

Paylocity Announces Second Quarter Fiscal Year 2016 Financial Results

Paylocity Announces Second Quarter Fiscal Year 2016 Financial Results Paylocity Announces Second Quarter Fiscal Year 2016 Financial Results Q2 2016 Total Revenue of $55.2 million, up 61% year-over-year Q2 2016 Recurring Revenue of $52.3 million, up 61% year-over-year ARLINGTON

More information

CLIENT RELATIONSHIP DISCLOSURE STATEMENT

CLIENT RELATIONSHIP DISCLOSURE STATEMENT A. INTRODUCTION CLIENT RELATIONSHIP DISCLOSURE STATEMENT Securities legislation in Canada requires Deans Knight Capital Management Ltd. ( Deans Knight or the firm ) to provide you with certain information

More information

SLM CORPORATION SUPPLEMENTAL FINANCIAL INFORMATION FIRST QUARTER 2006 (Dollars in millions, except per share amounts, unless otherwise stated)

SLM CORPORATION SUPPLEMENTAL FINANCIAL INFORMATION FIRST QUARTER 2006 (Dollars in millions, except per share amounts, unless otherwise stated) SLM CORPORATION SUPPLEMENTAL FINANCIAL INFORMATION FIRST QUARTER 2006 (Dollars in millions, except per share amounts, unless otherwise stated) The following supplemental information should be read in connection

More information

BDI BioEnergy Internat. 14.5 Buy

BDI BioEnergy Internat. 14.5 Buy 20/08/13 20/10/13 20/12/13 20/02/14 20/04/14 20/06/14 20/08/14 20/10/14 20/12/14 20/02/15 20/04/15 20/06/15 MATELAN Research Update Note Price as of 20/08/15: 10.80 21 August 2015 Company / Sector Fair

More information

Colliers International Group Inc. Investor Presentation

Colliers International Group Inc. Investor Presentation Colliers International Group Inc. Investor Presentation Basis of Presentation All amounts in millions of US Dollars unless otherwise noted. Adjusted EBITDA ( AEBITDA ) and Adjusted EPS ( AEPS ) are non-gaap

More information

Performance Food Group Company Reports Second-Quarter and First-Half Fiscal 2016 Results; Reaffirms Full-Year Fiscal 2016 Adjusted EBITDA Outlook

Performance Food Group Company Reports Second-Quarter and First-Half Fiscal 2016 Results; Reaffirms Full-Year Fiscal 2016 Adjusted EBITDA Outlook NEWS RELEASE For Immediate Release February 3, 2016 Investors: Michael D. Neese VP, Investor Relations (804) 287-8126 michael.neese@pfgc.com Media: Joe Vagi Manager, Corporate Communications (804) 484-7737

More information

Contacts: Investor Relations Evan Black & Kristina Carbonneau 800.493.8219 InvestorRelations@santanderconsumerusa.com

Contacts: Investor Relations Evan Black & Kristina Carbonneau 800.493.8219 InvestorRelations@santanderconsumerusa.com Contacts: Investor Relations Evan Black & Kristina Carbonneau 800.493.8219 InvestorRelations@santanderconsumerusa.com Media Relations Laurie Kight 214.801.6455 LKight@santanderconsumerusa.com Santander

More information

The Advisors Inner Circle Fund. Westwood LargeCap Value Fund. Summary Prospectus March 1, 2015 Ticker: Institutional Shares WHGLX

The Advisors Inner Circle Fund. Westwood LargeCap Value Fund. Summary Prospectus March 1, 2015 Ticker: Institutional Shares WHGLX The Advisors Inner Circle Fund Westwood LargeCap Value Fund Summary Prospectus March 1, 2015 Ticker: Institutional Shares WHGLX Before you invest, you may want to review the Fund s complete prospectus,

More information

FIRESWIRL TECHNOLOGIES INC.

FIRESWIRL TECHNOLOGIES INC. FIRESWIRL TECHNOLOGIES INC. Management Discussion and Analysis of the Financial Condition and Results of Operation, for the three months ended March 31, 2007 and 2006. 1 MANAGEMENT DISCUSSION AND ANALYSIS

More information

APX GROUP HOLDINGS, INC. REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS

APX GROUP HOLDINGS, INC. REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS APX GROUP HOLDINGS, INC. REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS 1st Quarter Financial Highlights Total revenues of $130.2 million for the first quarter 2014, an increase of 21.8%, compared to $106.9

More information

FISCAL Q SUPPLEMENTAL FINANCIAL INFORMATION

FISCAL Q SUPPLEMENTAL FINANCIAL INFORMATION FISCAL Q2 2016 SUPPLEMENTAL FINANCIAL INFORMATION Safe Harbor Statement This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E

More information

YOUR VOTE IS IMPORTANT! VOTE THE WHITE PROXY CARD TODAY FOR THE AMALGAMATION AGREEMENT BETWEEN PARTNERRE AND AXIS CAPITAL

YOUR VOTE IS IMPORTANT! VOTE THE WHITE PROXY CARD TODAY FOR THE AMALGAMATION AGREEMENT BETWEEN PARTNERRE AND AXIS CAPITAL PRE 425 6/11/2015 Section 1: 425 (FORM 425) Filed by PartnerRe Ltd. pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject

More information

Strength in Microsoft Cloud Highlights Q3 Results

Strength in Microsoft Cloud Highlights Q3 Results Strength in Microsoft Cloud Highlights Q3 Results Increasing usage of Microsoft Azure, Office 365, Bing and Xbox Live contributes to Q3 growth REDMOND, Wash. April 23, 2015 Microsoft Corp. today announced

More information

CenterPoint Energy Inc. (CNP-NYSE)

CenterPoint Energy Inc. (CNP-NYSE) December 30, 2014 CenterPoint Energy Inc. (CNP-NYSE) Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Underperform Date of Last Change 06/29/2009 Current Price (12/29/14) $24.29 Target

More information

RESEARCH IN MOTION REPORTS SECOND QUARTER RESULTS

RESEARCH IN MOTION REPORTS SECOND QUARTER RESULTS FOR IMMEDIATE RELEASE September 16, RESEARCH IN MOTION REPORTS SECOND QUARTER RESULTS Waterloo, ON Research In Motion Limited (RIM) (Nasdaq: RIMM; TSX: RIM), a world leader in the mobile communications

More information

Second Quarter 2013 Non-GAAP

Second Quarter 2013 Non-GAAP Resources, Inc. Second Quarter 2013 Non-GAAP Reconciliation and Appendix Operating Results June 30, % June 30, % (in thousands) 2013 2012 change 2013 2012 change Revenues (excludes derivatives) Oil $ 4,524

More information

NETSUITE ANNOUNCES FOURTH QUARTER AND FISCAL 2013 FINANCIAL RESULTS

NETSUITE ANNOUNCES FOURTH QUARTER AND FISCAL 2013 FINANCIAL RESULTS Exhibit 99.1 Investor Relations Contact: Media Contact: Carolyn Bass Mei Li Market Street Partners NetSuite Inc. 415.445.3232 650.627.1063 IR@netsuite.com meili@netsuite.com NETSUITE ANNOUNCES FOURTH QUARTER

More information

Palangana expansion fully permitted; Burke Hollow receives disposal well permit. Associate: Michael Wichterle, MBA,

Palangana expansion fully permitted; Burke Hollow receives disposal well permit. Associate: Michael Wichterle, MBA, Equity Research Price (C$) Volume (M) May 27, 2015 Research Update URANIUM ENERGY CORP. Palangana expansion fully permitted; Burke Hollow receives disposal well permit EVENT Uranium Energy Corp. announced

More information

BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability

BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability NEWS RELEASE FOR IMMEDIATE RELEASE June 19, BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability Waterloo, ON BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile communications,

More information

FOOT LOCKER, INC. REPORTS THIRD QUARTER RESULTS

FOOT LOCKER, INC. REPORTS THIRD QUARTER RESULTS N E W S R E L E A S E FOOT LOCKER, INC. REPORTS THIRD QUARTER RESULTS Contact: Peter D. Brown Senior Vice President, Chief Information Officer and Investor Relations Foot Locker, Inc. (22) 720-4254 Third

More information

WILLIAMS-SONOMA, INC.

WILLIAMS-SONOMA, INC. WILLIAMS-SONOMA, INC. 3250 Van Ness Avenue San Francisco, CA 94109 CONT: Julie P. Whalen EVP, Chief Financial Officer (415) 616-8524 Gabrielle L. Rabinovitch Vice President, Investor Relations (415) 616-7727

More information

Forward-Looking Statements

Forward-Looking Statements MANAGEMENT S DISCUSSION AND ANALYSIS For the three months ended March 31, 2010 Dated May 21, 2010 Management's Discussion and Analysis ( MD&A ) is intended to help shareholders, analysts and other readers

More information

N E W S R E L E A S E

N E W S R E L E A S E N E W S R E L E A S E Investors: Brett Manderfeld John Penshorn Media: Don Nathan Tyler Mason Vice President Senior Vice President Senior Vice President Vice President 952-936-7216 952-936-7214 952-936-1885

More information

Monster Worldwide Reports Third Quarter 2015 Results

Monster Worldwide Reports Third Quarter 2015 Results Monster Worldwide Reports Third Quarter 2015 Results Third Quarter Financial Highlights: o Company Exceeds Expectations on All Profitability Metrics For the 5th Consecutive Quarter Adjusted EBITDA Including

More information

First Quarter 2015 Earnings Conference Call. 20 February 2015

First Quarter 2015 Earnings Conference Call. 20 February 2015 First Quarter 2015 Earnings Conference Call 20 February 2015 Safe Harbor Statement & Disclosures The earnings call and accompanying material include forward-looking comments and information concerning

More information

Herzogenaurach, Germany, July 27, 2004 PUMA AG announces its consolidated nd

Herzogenaurach, Germany, July 27, 2004 PUMA AG announces its consolidated nd P Quarter P Half-Year For immediate release MEDIA CONTACT: INVESTOR CONTACT: U.S.A.: Lisa Beachy, Tel. +1 617 488 2945 Europe: Ulf Santjer, Tel. +49 9132 81 2489 Dieter Bock, Tel. +49 9132 81 2261 Herzogenaurach,

More information

SPDR S&P 400 Mid Cap Value ETF

SPDR S&P 400 Mid Cap Value ETF SPDR S&P 400 Mid Cap Value ETF Summary Prospectus-October 31, 2015 Before you invest in the SPDR S&P 400 Mid Cap Value ETF (the Fund ), you may want to review the Fund's prospectus and statement of additional

More information

Accenture Reports Strong First-Quarter Fiscal 2017 Results. -- Revenues increase 6% in U.S. dollars and 7% in local currency to $8.

Accenture Reports Strong First-Quarter Fiscal 2017 Results. -- Revenues increase 6% in U.S. dollars and 7% in local currency to $8. Accenture Reports Strong First-Quarter Fiscal 2017 Results -- Revenues increase 6% in U.S. dollars and 7% in local currency to $8.5 billion -- -- EPS are $1.58, a 23% increase, including $0.18 positive

More information

AGILYSYS FISCAL 2016 SECOND QUARTER REVENUE INCREASES 13% TO $29.6 MILLION INCLUSIVE OF 35% YEAR OVER YEAR INCREASE IN SUBSCRIPTION REVENUE

AGILYSYS FISCAL 2016 SECOND QUARTER REVENUE INCREASES 13% TO $29.6 MILLION INCLUSIVE OF 35% YEAR OVER YEAR INCREASE IN SUBSCRIPTION REVENUE AGILYSYS FISCAL 2016 SECOND QUARTER REVENUE INCREASES 13% TO $29.6 MILLION INCLUSIVE OF 35% YEAR OVER YEAR INCREASE IN SUBSCRIPTION REVENUE Revenue in First Half of Fiscal 2016 Improves 14% to $57.1 Million,

More information

Delphi Management, Inc. Firm Brochure (Part 2A of Form ADV)

Delphi Management, Inc. Firm Brochure (Part 2A of Form ADV) Item 1. Cover Page Delphi Management, Inc. Firm Brochure (Part 2A of Form ADV) This brochure provides information about the qualifications and business practices of Delphi Management, Inc. ( Delphi ).

More information

Hewlett-Packard Separation Will Create Two New Industry-Leading Public Companies

Hewlett-Packard Separation Will Create Two New Industry-Leading Public Companies Hewlett-Packard Separation Will Create Two New Industry-Leading Public Companies Investor Presentation October 6, 2014 Safe harbor This presentation contains forward-looking statements that involve risks,

More information

AGF MANAGEMENT LIMITED EARNINGS CONFERENCE CALL SECOND QUARTER 2014 JUNE 24, 2014

AGF MANAGEMENT LIMITED EARNINGS CONFERENCE CALL SECOND QUARTER 2014 JUNE 24, 2014 AGF MANAGEMENT LIMITED EARNINGS CONFERENCE CALL SECOND QUARTER 2014 JUNE 24, 2014 CAUTION REGARDING FORWARD-LOOKING STATEMENTS The forward looking information is provided as of June 24, 2014. Certain information

More information

FLY LEASING REPORTS SECOND QUARTER 2010 FINANCIAL RESULTS AND REPURCHASE OF 1.4 MILLION SHARES

FLY LEASING REPORTS SECOND QUARTER 2010 FINANCIAL RESULTS AND REPURCHASE OF 1.4 MILLION SHARES FLY LEASING REPORTS SECOND QUARTER FINANCIAL RESULTS AND REPURCHASE OF 1.4 MILLION SHARES Dublin, Ireland, August 4, FLY Leasing Limited (NYSE: FLY) ( FLY ), a global lessor of modern, fuel-efficient commercial

More information

CFO Commentary on Full Year 2015 and Fourth-Quarter Results

CFO Commentary on Full Year 2015 and Fourth-Quarter Results Intel Corporation 2200 Mission College Blvd. Santa Clara, CA 95054-1549 CFO Commentary on Full Year 2015 and Fourth-Quarter Results Summary The fourth quarter was a strong finish to the year with record

More information

QSC AG. Company Presentation. Results Q2 2014 Cologne, August 11, 2014

QSC AG. Company Presentation. Results Q2 2014 Cologne, August 11, 2014 QSC AG Company Presentation Results Q2 2014 Cologne, August 11, 2014 AGENDA 1. Operating development Q2 2014 2. Financial development Q2 2014 3. Outlook for 2014 4. Questions & Answers 2 DISAPPOINTING

More information

VALUATION ANALYSIS APPENDIX B

VALUATION ANALYSIS APPENDIX B APPENDIX B THIS VALUATION ANALYSIS PRESENTS INFORMATION FOR ALL REORGANIZED DEBTORS ON A CONSOLIDATED BASIS. PRIOR TO THE HEARING TO APPROVE THE DISCLOSURE STATEMENT, THE DEBTORS WILL REPLACE THIS VALUATION

More information

Thomas A. Bessant, Jr. (817) 335-1100

Thomas A. Bessant, Jr. (817) 335-1100 Additional Information: Thomas A. Bessant, Jr. (817) 335-1100 For Immediate Release ********************************************************************************** CASH AMERICA FIRST QUARTER NET INCOME

More information

First-Quarter 2014 Financial Results

First-Quarter 2014 Financial Results First-Quarter 2014 Financial Results www.unisys.com/investor Ed Coleman Chairman & CEO Janet Haugen SVP & CFO April 22, 2014 Disclaimer Statements made by Unisys during today's presentation that are not

More information

Q1-2014 Financial Results Conference Call

Q1-2014 Financial Results Conference Call May XX 9th March 2014 2013 Q1-2014 Financial Results Conference Call 2 Speakers Live Dial-in Information Replay Dial-in Information Q4-2013 Conference and webcast details David Reis Erez Simha CEO CFO

More information